Gout keeps returning: why painkillers alone are not enough

Why manage uric acid when the pain has stopped?

Taking medicine when a toe hurts, stopping when it settles, then facing another swollen joint: for people with diagnosed, recurrent gout, treatment needs to address more than pain. Anti-inflammatory medicines treat the flare; urate-lowering medicines control uric acid over time. They have different roles.[1,2]

This also changes what matters when seeking care in China. A useful outcome is understanding why the current plan has not controlled the disease and establishing sustainable medication and monitoring, rather than simply switching painkillers.

Gout involves urate crystals. Pain subsiding does not prove that crystals have cleared or that blood uric acid has stayed at target. American College of Rheumatology patient information lists colchicine, nonsteroidal anti-inflammatory drugs and corticosteroids as options for inflammation during flares. Allopurinol and febuxostat lower uric acid by reducing its production.[1]

Jiangmen Central Hospital's April 2026 patient information gives common treatment targets of below 360 μmol/L without tophi and below 300 μmol/L with tophi. These are treatment targets, a different question from whether a laboratory result exceeds its reference range. The doctor should individualize the target.[2]

To judge the current plan, compare several uric acid results with the doses actually taken and dates of flares. One recent blood test rarely shows whether levels stayed at target, doses were missed or changes followed an adjustment.

Why can a flare occur after starting urate lowering?

Flares can still occur when urate-lowering treatment begins. The 2020 ACR guideline therefore recommends preventive anti-inflammatory treatment tailored to the patient when starting urate lowering, generally for 3–6 months, with further assessment if flares continue. This does not mean everyone should take the same medicine for the same duration.[3]

An early flare does not by itself show that urate-lowering medicine has failed or made the disease worse. The doctor needs to treat the flare, check the uric acid target and assess preventive treatment separately. Beijing Tsinghua Changgung Hospital's educational information for older adults also advises against stopping urate-lowering medicine solely because a flare occurs during treatment.[4]

Three common medicines: price is not the only consideration

A consultation in China may include allopurinol, febuxostat or benzbromarone. They are not interchangeable simply because one costs less. Tsinghua Changgung Hospital highlights factors that affect the choice:[4]

Allopurinol: HLA-B*5801 testing before use relates to assessment of severe hypersensitivity risk. Tell the doctor about previous drug rashes, test results and kidney function. Having taken a similar medicine in another country does not remove the need for assessment.

Febuxostat: caution is needed in older adults with cardiovascular or cerebrovascular disease. Disclose a history of heart attack or stroke rather than switching it yourself merely because it lowers uric acid.

Benzbromarone: it increases uric acid excretion, so stones and liver disease affect suitability. A history of kidney stones matters.

This source concerns older adults; its stepwise doses must not be applied directly to every adult. Patients need their own prescribed medicine name, dose and monitoring requirements, not a web page to use for self-prescribing.

What should follow-up resolve, and what cannot wait?

Both the Chinese educational material and the US guideline emphasize adjusting treatment according to follow-up, rather than keeping an unassessed dose indefinitely.[3,4] Before leaving, clarify the next uric acid and liver and kidney function tests, how to manage a flare, and who will adjust long-term medicine after returning home. Do not turn urate-lowering medicine into something taken only when it hurts.[4,5]

Diet, weight and alcohol management still matter, but cannot replace medication that is clearly indicated. Jiangmen Central Hospital stresses combining appropriate medicine with healthy habits, rather than treating medicine as permission to eat or drink without restraint.[2]

If a joint suddenly becomes red and swollen, pain keeps worsening, and fever, chills or marked general illness occur, seek prompt local medical care to rule out joint infection and other problems. Do not wait for a China appointment or simply increase painkillers based on previous gout experience.[5]

If language is a barrier to seeking care in China, consider SinoCareHub medical interpretation accompaniment. On-site English interpretation can help explain previous medicines and flares to the doctor and record important instructions and follow-up arrangements that day. Other languages require separate confirmation. Medicine selection and dose changes remain the doctor's decisions.